Bayer’s sevabertinib picks up a second-line indication for HER2-mutated disease, joining Boehringer’s zongertinib on the US ...
MedPage Today on MSN
New FDA-Approved Option for HER2-Mutated Lung Cancer
The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).
Your gut changes on GLP-1s — but you don’t have to feel miserable. These 23 probiotics smooth digestion, calm bloating, and ...
Foremost Clean Energy (FMST) announces the receipt of assay results for drillholes JL25-003 and JL25-004 from its ongoing 2025 drill program at ...
ʻIolani won a school-record fourth consecutive boys cross country state championship: Brendan Fujimoto, left, Tanner Kawamura ...
This Black Friday, BestQool invites everyone to pause, breathe, and take a moment for themselves. Even a brief daily red ...
From expanding access to veterinary medicine in rural communities to pioneering integrative approaches to support better health outcomes, VMX 2026, NAVC's annual veterinary meeting and expo, is ...
The California Department of Education released the official 2024–25 California Assessment of Student Performance and ...
ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP ...
A first grade teacher at Math and Science Success Academy in Tucson received an unexpected gift from the Fiesta Sports ...
Dr. Arleen Lamba is scaling Glo30 to over 100 location utilizing a franchise model to bring medical grade facials to ...
With me on today's call to discuss our fiscal first quarter results are Nikesh Arora, our chairman and chief executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback